Aesthetic Outcomes of Oncoplastic Breast Surgery for Breast Cancer in the Upper Inner Quadrant

NCT05179304 | Unknown

• 1 other identifier: 2021-KY-124-001
• Study Type: interventional
• Target: 109
• Locations: 1 country
• Sites: 1

Brief Summary

Oncoplastic breast surgery, combining oncological resection with plastic surgical techniques, has emerged as an important surgical strategy to optimize conventional breast-conserving surgery. The upper inner quadrant is one of the most difficult and challenging tumor locations for surgeons to perform oncoplastic breast surgery. There is a pressing need to develop a simple and effective oncoplastic surgical technique to cope with the unfavorable anatomy and location of tumors in the UIQ. Here, we present a new oncoplastic volume displacement technique for UIQ using the DSG flap. This trial was design to estimate the aesthetic outcomes of an oncoplastic technique using a droplet-shaped glandular flap for breast cancer in the upper inner quadrant.

Conditions

Oncoplastic Breast Surgery; Breast Cancer; Aesthetic Outcomes

Outcome Measures

Primary Outcomes (1)

• aesthetic outcomes

  ABNSW system. The total score was 15 points, outcomes were good when it was 11-14, fair when it was 6-10, and poor when it was 0-5.

  half a year to one year

Secondary Outcomes (3)

• Patients' quality of life

  half a year to one year

• Local recurrence

  half a year to one year

• Patients complications after surgery

  half a year to one year

Study Arms (1)

Oncoplastic technique with a droplet-shaped glandular flap

EXPERIMENTAL

Procedure: Oncoplastic technique with a droplet-shaped glandular flap

Interventions

Oncoplastic technique with a droplet-shaped glandular flap PROCEDURE

A droplet-shaped glandular flap (DSG) is in a shape of a water drop, with the pedicle at the top of the defect and the base underlying nipple-areolar complex (NAC). It runs from the outer upper quadrant to the center along a line parallel to the radial line. We harvest a DSG flap by dissociating the supplement mammary gland from the lateral of the defect after resection, developing deep to the pectoralis fascia, from the cusp at the defect and the round pore underlying nipple-areolar complex (NAC). The DSG flap was rotated inwards around the cusp, reaching the top of the defect. This tailored redistribution allowed the defects to be "plugged" with the lateral glandular flaps.

Oncoplastic technique with a droplet-shaped glandular flap

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Signed the informed consent.
• Female aged between 18 and 70 years.
• Pathologically diagnosed operable breast cancer.
• WHO Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
• Cancer located in the upper inner quadrant; Single tumor or multiple tumors in the same quadrant.
• The important organ functions meet the following criteria:
• WBC \>=3.0 x 10\^9/L; Neutrophilic granulocytes \>=1.5×10\^9/L; Platelet \>=100 x 10\^9/L; Hb \>=9 g/dL;
• Total bilirubin no more than 1.5 times the normal upper limit (ULN); AST and ALT no more than 1.5 times ULN; AKP no more than 2.5 times ULN;
• Serum creatinine no more than 1.5 times ULN or Clearance rate of creatinine \>= 60ml/min;
• Thyroid stimulating hormone (TSH) \<= ULN (T3, T4 levels need to be detected simultaneously if abnormalities, the patient can be included if T3, T4 levels is normal);
• LVEF basement \>= 50%.
• Adjust to the criteria of breast conserving surgery.

You may not qualify if:

• Multifocal or multicentric disease.
• Tumor localized in the central quadrant or the distance to the nipple \< 2 cm；
• Diffused calcifications with fine plemorphic or fine linear or fine-linear branching morphology.
• The ratio of tumor to breast \> 20%;
• The diameter of tumor is up to 4 cm;
• Women in the early or intermediate stage of pregnancy;
• Prior history of breast radiation;
• Any severe comorbidities, inability to give informed consent or unavailability for follow-up.

Sponsors & Collaborators

• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: lead

Study Sites (1)

Shicheng Su

Guangzhou, Guangdong, 510120, China

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Central Study Contacts

Shicheng Su, M.D.,Ph.d.

CONTACT

+8613631304227; sushch@mail.sysu.edu.cn

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director of Shuhua Breast Cancer Research Center of Sun Yat-Sen Memorial Hospital

Study Record Dates

• First Submitted: December 12, 2021
• First Posted: January 5, 2022
• Study Start: January 18, 2022
• Primary Completion: November 1, 2022
• Study Completion: November 1, 2022
• Last Updated: February 9, 2022

Record last verified: 2022-02

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)